A Study of Stereotactic Body Radiotherapy (SBRT) and Pluvicto (177Lu-PSMA-617) in People With Prostate Cancer

Full Title

STARLiT: STereotActic body Radiotherapy and 177Lutetium PSMA in Locally advanced prostate cancer: A Phase I/II Trial

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Daniel Gorovets’ office at 212-639-3983.

Protocol

25-322

Phase

Phase I/II (phases 1 and 2 combined)

Disease Status

Newly Diagnosed & Relapsed/Refractory

Investigator

ClinicalTrials.gov ID

NCT06574880